Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
This is a European Registry of patients with right heart thrombi (RiHT) detected at echocardiography. Right heart thrombi can be found relatively rare in approximately 3-4% of patients with acute pulmonary embolism (APE).
All of us have faced clinical problem how to manage such patients. Since there are no generally accepted recommendations we know that therapy selection can be very difficult.
Although recent Guidelines of European Society of Cardiology in management of acute pulmonary embolism underlined “RiHT, particularly mobile, are associated with a significantly increased early mortality risk in patients with acute PE. Immediate therapy is mandatory, but optimal treatment is controversial in the absence of controlled trials. Thrombolysis and embolectomy are probably both effective while anticoagulation alone seems to be less effective”.
The main goals of RiHTER are to assess the prognostic significance of right heart thrombi and their characteristics in pulmonary embolism (PE) in relation to established prognostic factors.
138 patients with RiHT form 17 centers from 8 European countries have been included into the Registry. Preliminary results of RiHTER were presented during ESC and ACC congresses and currently they are under the final analysis.
The internet based registry can be accessed at http://www.rihter.wum.edu.pl
RIHTER Organizing Committee
Piotr Pruszczyk, Poland Adam Torbicki, Poland Stavros Konstantinides, Germany Nicolas Meneveau, France Marcin Koć, project coordinator
© 2017 European Society of Cardiology. All rights reserved